Literature DB >> 31537978

The incidence of inflammation among patients suffering from cervix cancer with positive beta haemolytic streptococci cultures from genital tract.

Zefiryn Cybulski1, Bartosz Urbański2, Alicja Grabiec1, Zofia Talaga1, Michał Pawlak2, Żaneta Wareńczak-Florczak2, Andrzej Roszak2,3.   

Abstract

AIM: The main goal of this investigation was to evaluate the influence of positive beta haemolytic streptococci culture from the genital tract on patients receiving radiation therapy who suffer from cervical cancer. The other aim was to observe radiation therapy complications.
BACKGROUND: Group B streptococci (GBS), group C streptococci (GCS) and group G streptococci (GGS) have been described as frequent invasive pathogens in elderly patients, often in association with underlying medical conditions including immunodeficiency and cancer.
MATERIALS AND METHODS: In the years 2006-2015, vaginal swabs from 452 patients were examined. A total of 118 women with positive beta haemolytic streptococci (BHS) groups A, B, C, F, G cultures were analysed, of whom 111 were diagnosed with cervix cancer of IB to IVA degree according to the FIGO 1988 clinical classification.
RESULTS: Of the 452 patients suffering from cervix cancer 26.1% were positive for A, B, C, F or G group BHS isolated from the genital tract. All of the 114 examined strains were sensitive to beta-lactam antibiotics. The antimicrobials for which resistance was noted were erythromycin, clindamycin, ciprofloxacin and tetracycline.
CONCLUSIONS: Positive cultures of BHS from the genital tract were demonstrated to occur in patients with cervix cancer. Complications were found during radiotherapy in 30 (27%) of these patients, including 20 (18%) patients suffering from clinical symptoms of inflammation. When beta-lactam antibiotics are not recommended because of allergy, sensitivity tests to other drugs are necessary.

Entities:  

Keywords:  Beta haemolytic streptococci; Cervix cancer patients; Radiation therapy complications

Year:  2019        PMID: 31537978      PMCID: PMC6744521          DOI: 10.1016/j.rpor.2019.07.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  22 in total

1.  Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators.

Authors:  G J Tyrrell; L D Senzilet; J S Spika; D A Kertesz; M Alagaratnam; M Lovgren; J A Talbot
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

2.  Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects.

Authors:  K Ekelund; P Skinhøj; J Madsen; H B Konradsen
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

3.  Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.

Authors:  Alberto Villaseñor-Sierra; Eva Katahira; Abril N Jaramillo-Valdivia; María de los Angeles Barajas-García; Amy Bryant; Rayo Morfín-Otero; Francisco Márquez-Díaz; Juan Carlos Tinoco; José Sánchez-Corona; Dennis L Stevens
Journal:  Int J Infect Dis       Date:  2012-01-02       Impact factor: 3.623

4.  Group B streptococcal disease in nonpregnant adults.

Authors:  M M Farley
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

5.  Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons.

Authors:  Morven S Edwards; Marcia A Rench; Debra L Palazzi; Carol J Baker
Journal:  Clin Infect Dis       Date:  2005-01-07       Impact factor: 9.079

6.  Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.

Authors:  Debra L Palazzi; Marcia A Rench; Morven S Edwards; Carol J Baker
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

7.  Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B.

Authors:  Laura N Broyles; Chris Van Beneden; Bernard Beall; Richard Facklam; P Lynn Shewmaker; Paul Malpiedi; Pamala Daily; Arthur Reingold; Monica M Farley
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

8.  Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007.

Authors:  Tami H Skoff; Monica M Farley; Susan Petit; Allen S Craig; William Schaffner; Ken Gershman; Lee H Harrison; Ruth Lynfield; Janet Mohle-Boetani; Shelley Zansky; Bernadette A Albanese; Karen Stefonek; Elizabeth R Zell; Delois Jackson; Terry Thompson; Stephanie J Schrag
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

9.  Six-month multicenter study on invasive infections due to group B streptococci in Argentina.

Authors:  Horacio A Lopardo; Patricia Vidal; Paola Jeric; Daniela Centron; Hugo Paganini; Richard R Facklam; John Elliott
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Evaluation of the MicroScan MICroSTREP plus antimicrobial panel for testing β-hemolytic streptococci and viridans group streptococci.

Authors:  Sung Ju Kim; Young Uh; In Ho Jang; Kwan Soo Lee; Soon Deok Park; Kap Jun Yoon
Journal:  Korean J Lab Med       Date:  2011-06-28
View more
  2 in total

Review 1.  Interplay between inflammation and cancer.

Authors:  Igor Piotrowski; Katarzyna Kulcenty; Wiktoria Suchorska
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-13

2.  Differences between [18F]FLT and [18F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology.

Authors:  Ewa Burchardt; Zaneta Warenczak-Florczak; Paulina Cegła; Adam Piotrowski; Zefiryn Cybulski; Wojciech Burchardt; Andrzej Roszak; Witold Cholewiński
Journal:  Diagnostics (Basel)       Date:  2021-12-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.